Conventional and complementary therapies: a tale of two research standards? (2010)

Other · Levine MN · April 20, 2010

Levine MN, 2010-04-20: Accompanying editorial by Mark N. Levine arguing the Chabot study's observational design cannot establish that enzyme therapy is markedly inferior, and listing the design problems (arm-size imbalance, possible confounding by liver metastases).

Can it be concluded that their study proves that enzyme therapy is markedly inferior? On the basis of the study design, my answer is no.

p.1979

Levine MN, 2010-04-20: Accompanying editorial by Mark N. Levine arguing the Chabot study's observational design cannot establish that enzyme therapy is markedly inferior, and listing the design problems (arm-size imbalance, possible confounding by liver metastases). Study type: other.